Andrea Cercek
@AndreaCercek
Followers
3K
Following
238
Media
1
Statuses
9
Co-Director, @CYOC_MSK | GI Medical Oncologist @MSKCancerCenter Tweets are my own
Joined May 2021
Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced #RectalCancer. No radiation or surgery! @ASCO #ASCO22 @MSKCancerCenter
nejm.org
Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency i...
194
1K
5K
Congratulations to our team. Next chapter in Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine
nejm.org
Among patients with mismatch repair–deficient (dMMR), locally advanced rectal cancer, neoadjuvant checkpoint blockade eliminated the need for surgery in a high proportion of patients. Whether this ...
1
38
135
RT @NEJM: An analysis of published studies suggests that a longer duration of immune checkpoint inhibitor therapy is associated with a high….
0
31
0
RT @StadlerZsofia: So excited to share our data on #LynchSyndrome and risk of new neoplasia after immunotherapy Thank you to our terrific c….
0
18
0
RT @DrVickersMSK: Grateful to @SU2C for sharing the inspirational stories of patients who’ve benefitted from advances in cancer research in….
0
6
0
RT @YJanjigianMD: With super stars ⭐️⭐️ In #NYC @MSKCancerCenter waking up to messages & congrats calls from all over 🌎 on how absolutely….
0
16
0
Grateful for our incredible team @ldiaz1971, @LumishMelissa, @jjennasinopole, and Jill Weiss! @ASCO #ASCO22 @MSKCancerCenter .
12
12
205
RT @KarunaMDPhD: Super proud of our brilliant medical oncology fellow @LumishMelissa and her Tow Center for Developmental Oncology Career D….
0
11
0